Inovio Pharmaceuticals, Inc.
NASDAQ:INO
Overview | Financials
Company Name | Inovio Pharmaceuticals, Inc. |
Symbol | INO |
Currency | USD |
Price | 1.84 |
Market Cap | 66,424,000 |
Dividend Yield | 0% |
52-week-range | 1.74 - 14.75 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jacqueline E. Shea Ph.D. |
Website | https://www.inovio.com |
An error occurred while fetching data.
About Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD